|
Volumn 50, Issue 8, 2011, Pages 1466-1472
|
The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor-α inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in China.
a b b b b b b b b b b b b b b b b b
b
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOGLOBULIN G;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
NONSTEROID ANTIINFLAMMATORY AGENT;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
ADULT;
ANKYLOSING SPONDYLITIS;
ARTICLE;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ANTAGONISM;
FEMALE;
HEALTH STATUS;
HOSPITALIZATION;
HUMAN;
LUMBAR VERTEBRA;
MALE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATHOLOGY;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
SACROILIAC JOINT;
TREATMENT OUTCOME;
VALIDATION STUDY;
ZYGAPOPHYSEAL JOINT;
ADULT;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIBODIES, MONOCLONAL;
COHORT STUDIES;
FEMALE;
HEALTH STATUS;
HUMANS;
IMMUNOGLOBULIN G;
LUMBAR VERTEBRAE;
MAGNETIC RESONANCE IMAGING;
MALE;
RECEPTORS, TUMOR NECROSIS FACTOR;
SACROILIAC JOINT;
SEVERITY OF ILLNESS INDEX;
SPONDYLITIS, ANKYLOSING;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
YOUNG ADULT;
ZYGAPOPHYSEAL JOINT;
|
EID: 84862833269
PISSN: None
EISSN: 14620332
Source Type: Journal
DOI: 10.1093/rheumatology/ker087 Document Type: Article |
Times cited : (38)
|
References (0)
|